MCH ADVISORY RESEARCHMain site ↗
Real Estate

Health Care REITs

8 companies under coverage.

Coverage

Health Care REITs


Equity Research

Healthcare Realty Trust Incorporated (HR)

HOLD. 12-month probability-weighted target $21 (+11% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.3%
Equity Research

CareTrust REIT Inc. (CTRE)

HOLD. 12-month probability-weighted target $42 (+6% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

CTREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +3.9%
Equity Research

Welltower Inc (WELL)

HOLD. 12-month probability-weighted target $243 (+3% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

WELLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.3%
Equity Research

Omega Healthcare Investors Inc (OHI)

HOLD. 12-month probability-weighted target $49 (+5% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OHIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.2%
Equity Research

Ventas Inc (VTR)

HOLD. 12-month probability-weighted target $92 (+2% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

VTREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.3%
Equity Research

Healthpeak Properties Inc (DOC)

HOLD. 12-month probability-weighted target $21 (+1% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

DOCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.5%
Equity Research

Sabra Healthcare REIT Inc (SBRA)

HOLD. 12-month probability-weighted target $20 (-6% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SBRAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.0%
Equity Research

American Healthcare REIT, Inc. (AHR)

SELL. 12-month probability-weighted target $47 (-14% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AHREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.3%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed